Engineered protein inhibitors of proteases
1Dyax Corp, Cambridge, MA 02339, USA. anixon@dyax.com
Current Opinion in Drug Discovery & Development
|March 29, 2006
Summary
Maintaining proteolysis balance is crucial for health. Engineered protein inhibitors offer a promising therapeutic strategy for diseases caused by protease dysregulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Proteolysis, the breakdown of proteins, is tightly regulated in organisms.
- This regulation involves protease production, degradation, inactivation, and interaction with inhibitors.
- Dysregulation of proteolysis can lead to disease onset and progression.
Purpose of the Study:
- To explore therapeutic interventions for aberrant proteolysis.
- To investigate the potential of engineered protein inhibitors as a treatment strategy.
Main Methods:
- The study discusses the general principles of proteolysis control and dysregulation.
- It highlights the limitations of small-molecule inhibitor identification.
- The focus is on the potential of engineered protein inhibitors.
Main Results:
- Engineered protein inhibitors present a viable alternative to small-molecule approaches.
- These inhibitors can be designed to target specific overproduced proteases.
- They offer a potential solution for replacing absent endogenous inhibitors.
Conclusions:
- Aberrant proteolysis is a significant therapeutic target.
- Engineered protein inhibitors provide a novel and potentially more effective therapeutic avenue.
- This approach may overcome challenges associated with traditional small-molecule drug discovery.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...